Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00302
|
|||||
| Drug Name |
Coenzyme A
|
|||||
| Synonyms |
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Hyperlipoproteinemia [ICD11: 5C80] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H36N7O16P3S
|
|||||
| Canonical SMILES |
CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O
|
|||||
| InChI |
InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14-,15-,16+,20-/m1/s1
|
|||||
| InChIKey |
RGJOEKWQDUBAIZ-IBOSZNHHSA-N
|
|||||
| CAS Number |
CAS 85-61-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 767.5 | Topological Polar Surface Area | 348 | ||
| Heavy Atom Count | 48 | Rotatable Bond Count | 18 | |||
| Hydrogen Bond Donor Count | 10 | Hydrogen Bond Acceptor Count | 21 | |||
| XLogP |
-5.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
3312
, 584781
, 585803
, 7886704
, 8012126
, 8015117
, 8017121
, 820209
, 821306
, 821310
, 821978
, 821981
, 821983
, 822315
, 825209
, 826268
, 826273
, 826648
, 826649
, 827349
, 827479
, 828508
, 829102
, 829243
, 829831
, 829832
, 830028
, 830070
, 830114
, 831197
, 831239
, 832661
, 832832
, 832850
, 833892
, 835941
, 836037
, 836039
, 836309
, 836925
, 837304
, 838522
, 838860
, 841100
, 854565
, 854707
, 854711
, 854757
, 854939
, 854940
|
|||||
| ChEBI ID |
ChEBI:15346
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | GDC | Transporter Info | Graves disease carrier protein | Substrate | [2] | |
| PMP34 | Transporter Info | Peroxisomal membrane protein PMP34 | Substrate | [3] | ||
| SLC25A42 | Transporter Info | Mitochondrial coenzyme A transporter SLC25A42 | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | GDC | Transporter Info | Km = 140 microM | Yeast cells-GDC | [2] | |
| SLC25A42 | Transporter Info | Km = 71 microM | Liposomes reconstituted with SLC25A42 | [4] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01878227) Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia | |||||
| 2 | Biochemical characterization of a new mitochondrial transporter of dephosphocoenzyme A in Drosophila melanogaster. Biochim Biophys Acta Bioenerg. 2017 Feb;1858(2):137-146. | |||||
| 3 | The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme A, FAD and NAD+. Biochem J. 2012 Apr 1;443(1):241-7. | |||||
| 4 | A novel member of solute carrier family 25 (SLC25A42) is a transporter of coenzyme A and adenosine 3',5'-diphosphate in human mitochondria. J Biol Chem. 2009 Jul 3;284(27):18152-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.